[ad_1]
Boxhoorn L, Voermans RP, Bouwense SA, Bruno MJ, Verdonk RC, Boermeester MA, van Santvoort HC, Besselink MG. Acute pancreatitis. Lancet. 2020;396(10252):726–34.
Zheng Y, Zhou Z, Li H, Li J, Li A, Ma B, Zhang T, Liao Q, Ye Y, Zhang Z, et al. A multicenter research on etiology of acute pancreatitis in Beijing throughout 5 years. Pancreas. 2015;44(3):409–14.
Zhu Y, Pan X, Zeng H, He W, Xia L, Liu P, Zhu Y, Chen Y, Lv N. A Study on the Etiology, Severity, and Mortality of 3260 Patients With Acute Pancreatitis According to the Revised Atlanta Classification in Jiangxi, China Over an 8-Year Period. Pancreas. 2017;46(4):504–9.
Wu D, Zhang M, Xu S, Wu Ok, Wang N, Wang Y, Wu J, Lu G, Gong W, Ding Y, et al. Nonalcoholic Fatty Liver Disease Aggravated the Severity of Acute Pancreatitis in Patients. Biomed Res Int. 2019;2019:9583790.
Younossi ZM. Non-alcoholic fatty liver illness – A worldwide public well being perspective. J Hepatol. 2019;70(3):531–44.
Ding Y, Zhang M, Wang L, Yin T, Wang N, Wu J, Zhi J, Chen W, Wu Ok, Gong W, et al. Association of the hypertriglyceridemic waist phenotype and severity of acute pancreatitis. Lipids Health Dis. 2019;18(1):93.
Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, Saab S, Lu DS. Macrovesicular hepatic steatosis in residing associated liver donors: correlation between CT and histologic findings. Radiology. 2004;230(1):276–80.
Berglund L, Brunzell JD, Goldberg AC, Goldberg IJ, Sacks F, Murad MH, Stalenhoef AF. Evaluation and remedy of hypertriglyceridemia: an Endocrine Society medical observe guideline. J Clin Endocrinol Metab. 2012;97(9):2969–89.
Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by worldwide consensus. Gut. 2013;62(1):102–11.
Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction rating: a dependable descriptor of a fancy medical consequence. Crit Care Med. 1995;23(10):1638–52.
Lee PJ, Papachristou GI. New insights into acute pancreatitis. Nat Rev Gastroenterol Hepatol. 2019;16(8):479–96.
Mikolasevic I, Orlic L, Poropat G, Jakopcic I, Stimac D, Klanac A, Carovic F, Milic S. Nonalcoholic fatty liver and the severity of acute pancreatitis. Eur J Intern Med. 2017;38:73–8.
Pascual I, Sanahuja A, García N, Vázquez P, Moreno O, Tosca J, Peña A, Garayoa A, Lluch P, Mora F. Association of elevated serum triglyceride ranges with a extra extreme course of acute pancreatitis: Cohort evaluation of 1457 sufferers. Pancreatology. 2019;19(5):623–9.
Pothoulakis I, Paragomi P, Tuft M, Lahooti A, Archibugi L, Capurso G, Papachristou GI. Association of Serum Triglyceride Levels with Severity in Acute Pancreatitis: Results from an International. Multicenter Cohort Study Digestion. 2021;102(5):809–13.
Wan J, He W, Zhu Y, Zhu Y, Zeng H, Liu P, Xia L, Lu N. Stratified evaluation and medical significance of elevated serum triglyceride ranges in early acute pancreatitis: a retrospective research. Lipids Health Dis. 2017;16(1):124.
Cotter TG, Rinella M. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology. 2020;158(7):1851–64.
Xiao B, Zhang XM, Jiang ZQ, Tang W, Huang XH, Yang L, Feng ZS. Fatty liver in acute pancreatitis: traits in magnetic resonance imaging. J Comput Assist Tomogr. 2012;36(4):400–5.
Wang L, Xu T, Wang R, Wang X, Wu D. Hypertriglyceridemia Acute Pancreatitis: Animal Experiment Research. Dig Dis Sci. 2022;67(3):761–72.
Camilleri M, Malhi H, Acosta A. Gastrointestinal Complications of Obesity. Gastroenterology. 2017;152(7):1656–70.
Sadr-Azodi O, Orsini N, Andrén-Sandberg Å, Wolk A. Abdominal and whole adiposity and the danger of acute pancreatitis: a population-based potential cohort research. Am J Gastroenterol. 2013;108(1):133–9.
Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18(10):689–700.
Testoni PA. Acute recurrent pancreatitis: Etiopathogenesis, prognosis and remedy. World J Gastroenterol. 2014;20(45):16891–901.
Maltais M, Brisson D, Gaudet D. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia. J Clin Med. 2021;10(4):669.
Pitt HA. Hepato-pancreato-biliary fats: the great, the dangerous and the ugly. HPB (Oxford). 2007;9(2):92–7.
Zvonic S, Lefevre M, Kilroy G, Floyd ZE, DeLany JP, Kheterpal I, Gravois A, Dow R, White A, Wu X, et al. Secretome of main cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol Cell Proteomics. 2007;6(1):18–28.
Karpavicius A, Dambrauskas Z, Sileikis A, Vitkus D, Strupas Ok. Value of adipokines in predicting the severity of acute pancreatitis: complete evaluate. World J Gastroenterol. 2012;18(45):6620–7.
Hou S, Tang X, Cui H, Liu C, Bai X, Shi L, Shi Y. Fatty liver illness is related to the severity of acute pancreatitis: A scientific evaluate and meta-analysis. Int J Surg. 2019;65:147–53.
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi Ok, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The prognosis and administration of nonalcoholic fatty liver illness: Practice steerage from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57.
[adinserter block=”4″]
[ad_2]
Source link